Bionano Genomics, Inc.
BNGO
$4.08
-$0.02-0.49%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.95M | 18.94M | 28.32M | 66.77M | 63.58M |
| Total Receivables | 5.32M | 6.36M | 8.51M | 9.66M | 8.97M |
| Inventory | 14.32M | 19.48M | 19.59M | 22.89M | 26.43M |
| Prepaid Expenses | 4.39M | 4.79M | 4.75M | 1.10M | 5.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.00M | 11.01M | 24.45M | 39.69M | -- |
| Total Current Assets | 46.98M | 60.57M | 85.61M | 140.12M | 104.54M |
|
|
|||||
| Total Current Assets | 46.98M | 60.57M | 85.61M | 140.12M | 104.54M |
| Net Property, Plant & Equipment | 26.18M | 32.49M | 33.60M | 32.48M | 30.99M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 11.05M | 30.02M | 31.73M | 33.97M | 35.77M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.16M | 6.29M | 7.05M | 7.83M | 10.61M |
| Total Assets | 87.36M | 129.36M | 158.00M | 214.40M | 181.90M |
|
|
|||||
| Total Accounts Payable | 8.70M | 8.73M | 9.84M | 10.38M | 15.37M |
| Total Accrued Expenses | 4.60M | 3.80M | 5.86M | 6.58M | 10.24M |
| Short-term Debt | 14.95M | 19.36M | 29.08M | 69.80M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.22M | 2.41M | 2.46M | 2.44M | 2.46M |
| Total Finance Division Other Current Liabilities | 2.47M | 2.87M | 11.26M | 10.82M | 12.12M |
| Total Other Current Liabilities | 2.47M | 2.87M | 11.26M | 10.82M | 12.12M |
| Total Current Liabilities | 32.95M | 37.18M | 58.51M | 100.03M | 40.19M |
|
|
|||||
| Total Current Liabilities | 32.95M | 37.18M | 58.51M | 100.03M | 40.19M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 14.95M | 19.36M | 29.08M | 69.80M | -- |
| Capital Leases | 5.28M | 5.81M | 6.33M | 7.18M | 7.68M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 263.00K | 6.05M | 10.39M | 11.04M | 15.03M |
| Total Liabilities | 38.49M | 49.03M | 75.22M | 118.25M | 62.91M |
|
|
|||||
| Common Stock & APIC | 720.43M | 709.19M | 695.42M | 677.34M | 656.41M |
| Retained Earnings | -673.10M | -628.85M | -612.63M | -581.21M | -537.32M |
| Treasury Stock & Other | 1.53M | -3.00K | -16.00K | 23.00K | -93.00K |
| Total Common Equity | 48.87M | 80.34M | 82.77M | 96.16M | 119.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.87M | 80.34M | 82.77M | 96.16M | 119.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.87M | 80.34M | 82.77M | 96.16M | 119.00M |
|
|
|||||
